(CIDRAP) A new study in the American Journal of Respiratory and Critical Care Medicine reveals about an 11% incidence of residual lung damage—known as interstitial lung disease—after COVID-19 hospitalization. Interstitial lung disease is a broad category of lung damage and disease defined by fibrotic scarring. The damage is often irreversible. Link to Study
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.